Clinical Trial Update: Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial TRANSCEND-T2D-3 comparing retatrutide to placebo in adults with type 2 diabetes and moderate to severe renal impairment on basal insulin,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Retatrutide (retatrutide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes | Phase 3 | Status: ACTIVE_NOT_RECRUITING